KPT-330
KPT-330 inhibited proliferation and induced cell cycle arrest and apoptosis-related proteins in 11 NSCLC cells lines. Moreover, the combination of KPT-330 with cisplatin synergistically enhanced the cell kill of the NSCLC cells in vitro. Human NSCLC tumours growing in immunodeficient mice were markedly inhibited by KPT-330. Also, KPT-330 was effective even against NSCLC cells with a transforming mutation of either exon 20 of EGFR, TP53, phosphatase and tensin homologue, RAS or PIK3CA, suggesting the drug might be effective against a variety of lung Ys irrespective of their driver mutation.
Product Specifications
CAS Number
1421923-86-5
Product Name Alternative
(E) -RN
Purity
>98% (HPLC)
Solubility
Soluble in DMSO
Smiles
C1=CN=C (C=N1) NNC (=O) /C=C/N2C=NC (=N2) C3=CC (=CC (=C3) C (F) (F) F) C (F) (F) F
Molecular Formula
C17H11F6N7O
Molecular Weight
443.31
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Explore Other Products
Browse additional items from our catalog
CELF6 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Probable Bifunctional Methylenetetrahydrofolate Dehydrogenase/cyclohydrolase 2 (MTHFD2L) Antibody